![Marylinn Munson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marylinn Munson
Direktor/Vorstandsmitglied bei Recombinetics, Inc.
Profil
Marylinn Munson is currently a Director at Recombinetics, Inc. She previously worked as a Principal at Molecular Dynamics, Inc., Ngen, Inc., Agilent Technologies, Inc., and Illumina, Inc. She also served as Vice President-Business Development at Biomatrica, Inc. and as a Principal at Amersham Pharmacia Biotech Corp.
Ms. Munson received her undergraduate degree from the University of Oregon.
Aktive Positionen von Marylinn Munson
Unternehmen | Position | Beginn |
---|---|---|
Recombinetics, Inc.
![]() Recombinetics, Inc. Packaged SoftwareTechnology Services Recombinetics, Inc. operates as a gene editing technology company with a platform in therapeutics development. It uses genetic technologies to improve the health of people, animals, and the environment. The firms offers transplantable cells, tissues and organs for patients, accelerating drug, device therapy, and animal health, welfare and sustainability services. Recombinetics was founded by Scott C. Fahrenkrug in 2008 and is headquartered in Eagan, MN. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Marylinn Munson
Unternehmen | Position | Ende |
---|---|---|
Biomatrica, Inc.
![]() Biomatrica, Inc. BiotechnologyHealth Technology Biomatrica, Inc. produces reagents and devices used for sample collection and analysis in diagnostics systems, nucleic acid analysis, and bio banking. Its technology is used to protect analyst in samples at the molecular and cellular level, chemically position laboratory workflows on microfluidics chips. The firm’s products include DNAstable, DNAgard, RNAstable and RNAgard. The company was founded by Judy L. Müller-Cohn and Rolf Müller in 2004 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01.12.2011 |
Molecular Dynamics, Inc.
![]() Molecular Dynamics, Inc. Wholesale DistributorsDistribution Services Molecular Dynamics, Inc. makes and markets high performance image acquisition and analysis instrumentation | Corporate Officer/Principal | - |
Amersham Pharmacia Biotech Corp. | Corporate Officer/Principal | - |
NGEN INC | Corporate Officer/Principal | - |
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Ausbildung von Marylinn Munson
University of Oregon | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ILLUMINA, INC. | Health Technology |
AGILENT TECHNOLOGIES, INC. | Commercial Services |
Private Unternehmen | 5 |
---|---|
Biomatrica, Inc.
![]() Biomatrica, Inc. BiotechnologyHealth Technology Biomatrica, Inc. produces reagents and devices used for sample collection and analysis in diagnostics systems, nucleic acid analysis, and bio banking. Its technology is used to protect analyst in samples at the molecular and cellular level, chemically position laboratory workflows on microfluidics chips. The firm’s products include DNAstable, DNAgard, RNAstable and RNAgard. The company was founded by Judy L. Müller-Cohn and Rolf Müller in 2004 and is headquartered in San Diego, CA. | Health Technology |
Ngen, Inc.
![]() Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
Amersham Pharmacia Biotech Corp. | |
Molecular Dynamics, Inc.
![]() Molecular Dynamics, Inc. Wholesale DistributorsDistribution Services Molecular Dynamics, Inc. makes and markets high performance image acquisition and analysis instrumentation | Distribution Services |
Recombinetics, Inc.
![]() Recombinetics, Inc. Packaged SoftwareTechnology Services Recombinetics, Inc. operates as a gene editing technology company with a platform in therapeutics development. It uses genetic technologies to improve the health of people, animals, and the environment. The firms offers transplantable cells, tissues and organs for patients, accelerating drug, device therapy, and animal health, welfare and sustainability services. Recombinetics was founded by Scott C. Fahrenkrug in 2008 and is headquartered in Eagan, MN. | Technology Services |